首页> 外文OA文献 >Once-Daily versus Twice-Daily Lamivudine, in Combination with Zidovudine and Efavirenz, for the Treatment of Antiretroviral-Naive Adults with HIV Infection: A Randomized Equivalence Trial

【2h】

Once-Daily versus Twice-Daily Lamivudine, in Combination with Zidovudine and Efavirenz, for the Treatment of Antiretroviral-Naive Adults with HIV Infection: A Randomized Equivalence Trial

机译：每日与两次每日拉米夫定，与Zidovudine和Efaviraenz的组合，用于治疗艾滋病毒感染的抗逆转录病毒 - 幼稚成年人：随机等同试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
E. DeJesus; D. McCarty; C. F. Farthing; D. D. Shortino; B. Grinsztejn; D. A. Thomas; S. R. Schrader; S. A. Castillo; M. G. Sension; K. Gough; S. J. Madison;
展开▼
作者单位

展开▼
年度 2004
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial. [J] . Staszewski S, Keiser P, Montaner J, JAMA: the Journal of the American Medical Association . 2001,第9期

机译：在未经抗逆转录病毒治疗的HIV感染成年人中，阿巴卡韦-拉米夫定-齐多夫定与茚地那韦-拉米夫定-齐多夫定：一项随机等效试验。
2. A randomized, controlled trial of initial anti-retroviral therapy with abacavir/lamivudine/zidovudine twice-daily compared to atazanavir once-daily with lamivudine/zidovudine twice-daily in HIV-infected patients over 48 weeks (ESS100327, the ACTION Study) [J] . Princy N Kumar, Patricia Salvato, Anthony LaMarca, AIDS Research and Therapy . 2009,第1期

机译：在48周内，每天两次对阿巴卡韦/拉米夫定/齐多夫定进行抗逆转录病毒治疗的随机对照试验与每天两次拉米夫定/齐多夫定对阿扎那韦进行比较，对HIV感染患者进行了抗逆转录病毒治疗（ESS100327，作用研究）
3. Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of HIV type 1 infection: final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903. [J] . Berenguer J, Gonzalez J, Ribera E, Clinical infectious diseases . 2008,第8期

机译：地高辛，拉米夫定和依非韦伦与齐多夫定，拉米夫定和依非韦伦用于HIV 1型感染的初始治疗：一项前瞻性，随机，非劣效性临床试验GESIDA 3903的最终分析（48周）。
4. Once-daily Nadroparin Versus Twice-daily Nadroparin in the Treatment of Patients with Acute Coronary Syndromes: The SAFRAX Study [C] . V. Hricak, A. Leizorovic International Congress on Thrombosis . 2006

机译：每日一日奈多林与每次每日Nadroparin治疗患者急性冠状动脉综合征患者：Safrax研究
5. Cost effectiveness analysis of abacavir/lamivudine versus tenofovir/emtricitabine combination therapy as part of highly active antiretroviral therapy in treatment naive HIV-infected patients. [D] . Giguere, Pierre. 2010

机译：阿巴卡韦/拉米夫定与替诺福韦/恩曲他滨联合疗法作为高活性抗逆转录病毒疗法治疗未受HIV感染的患者的成本效益分析。
6. A randomized controlled trial of initial anti-retroviral therapy with abacavir/lamivudine/zidovudine twice-daily compared to atazanavir once-daily with lamivudine/zidovudine twice-daily in HIV-infected patients over 48 weeks (ESS100327 the ACTION Study) [O] . Princy N Kumar, Patricia Salvato, Anthony LaMarca, 2009

机译：在48周内每天两次对阿巴卡韦/拉米夫定/齐多夫定进行抗逆转录病毒治疗的随机对照试验与每天两次拉米夫定/齐多夫定对阿扎那韦进行比较对HIV感染患者进行抗逆转录病毒治疗（ESS100327作用研究）
7. A randomized, controlled trial of initial anti-retroviral therapy with abacavir/lamivudine/zidovudine twice-daily compared to atazanavir once-daily with lamivudine/zidovudine twice-daily in HIV-infected patients over 48 weeks (ESS100327, the ACTION Study) [O] . McClernon Daniel, Patel Parul, DeJesus Edwin, 2009

机译：在48周内，每天两次对阿巴卡韦/拉米夫定/齐多夫定进行抗逆转录病毒治疗的随机对照试验与每天两次拉米夫定/齐多夫定对阿扎那韦进行比较，对HIV感染患者进行抗逆转录病毒治疗（ESS100327，作用研究）
8. ACTG 320: A Randomized Double-Blind, Phase III Study of Indinavir Sulfate (IDV) with Open-Label ZDV or Stavudine (d4T) and Lamivudine (3TC) in Subjects with HIV Infection with CD4 Cell Counts < = 200 Cells/mm3 and > = 3 Months of Prior Zidovudine Experien [R] . 1997

机译：aCTG 320：一项随机双盲，III期研究的印地那韦硫酸盐（IDV）与开放标签ZDV或司他夫定（d4T）和拉米夫定（3TC）的HIV感染受试者CD4细胞计数<= 200个细胞/ mm3和> = 3个月的Zidovudine Experien

Once-Daily versus Twice-Daily Lamivudine, in Combination with Zidovudine and Efavirenz, for the Treatment of Antiretroviral-Naive Adults with HIV Infection: A Randomized Equivalence Trial

著录项

相似文献

相关主题

期刊订阅